Notice: This company has been marked as potentially delisted and may not be actively trading. Reneo Pharmaceuticals (RPHM) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for Reneo Pharmaceuticals (NASDAQ:RPHM)CurrentInstitutional OwnershipPercentage90.98%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$10.88MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$288.17K Get RPHM Insider Trade Alerts Want to know when executives and insiders are buying or selling Reneo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RPHM Institutional Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Reneo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC214,499$365K0.0%+6.7%0.642% 11/15/2024 Ikarian Capital LLC1,025,668$1.74M0.2%N/A3.068% 11/14/2024 Vestal Point Capital LP799,400$1.36M0.1%+46.7%2.391% 11/5/2024 BML Capital Management LLC3,457,395$5.88M3.5%+29.4%10.342% 9/16/2024 Point72 Asia Singapore Pte. Ltd.18,027$27K0.0%N/A0.054% 8/20/2024 Nantahala Capital Management LLC547,804$846K0.0%N/A1.639% Get the Latest News and Ratings for RPHM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024 Point72 Asia Singapore Pte. Ltd.18,027$27K0.0%N/A0.054% 8/12/2024 Highbridge Capital Management LLC2,915,376$4.40M0.1%+6.5%8.723% 8/9/2024 Renaissance Technologies LLC442,200$668K0.0%-25.5%1.323% 5/7/2024 Marquette Asset Management LLC73,770$122K0.0%N/A0.221% 5/2/2024 Fifth Lane Capital LP32,635$54K0.0%-18.4%0.098% 4/23/2024 BML Capital Management LLC2,177,913$3.62M2.4%+65.7%6.517% 2/15/2024 Octagon Capital Advisors LP2,250,000$3.60M0.6%-1.3%6.754% 2/14/2024 Pale Fire Capital SE30,100$48K0.0%+102.7%0.090% 2/14/2024 Vestal Point Capital LP400,000$640K0.1%N/A1.201% 2/12/2024 Highbridge Capital Management LLC1,121,704$1.80M0.1%N/A3.367% 2/7/2024 Jump Financial LLC25,315$41K0.0%N/A0.076% 1/30/2024 BML Capital Management LLC1,314,229$2.10M1.6%N/A3.945% 1/12/2024 SG Americas Securities LLC22,097$35K0.0%N/A0.066% 11/15/2023 Adage Capital Partners GP L.L.C.65,000$495K0.0%N/A0.192% 11/14/2023 Eventide Asset Management LLC2,078,142$15.83M0.3%+18.8%6.148% 11/14/2023 Pale Fire Capital SE14,851$113K0.0%N/A0.044% 11/7/2023 Dorsey Wright & Associates3,673$28K0.0%N/A0.011% 11/7/2023 Barclays PLC78,118$595K0.0%+5.7%0.231% 10/24/2023 Bank of New York Mellon Corp35,963$274K0.0%+13.1%0.106% 9/8/2023Tucker Asset Management LLC36,753$241K0.1%N/A0.109% 8/14/2023 Great Point Partners LLC1,083,317$7.11M1.4%+796.3%3.218% 8/11/2023 Franklin Resources Inc.1,345,145$8.82M0.0%+230.0%3.996% 8/11/2023 ExodusPoint Capital Management LP555,316$3.64M0.0%+125.9%1.650% 8/4/2023 American International Group Inc.4,659$31K0.0%N/A0.014% 8/4/2023 Carlyle Group Inc.2,698,957$17.68M0.6%+30.1%8.019% 8/2/2023 MAI Capital Management66,487$436K0.0%+24.4%0.198% 6/1/2023 Prelude Capital Management LLC14,800$89K0.0%N/A0.044% 5/16/2023 Great Point Partners LLC120,864$723K0.1%N/A0.481% 5/11/2023 ExodusPoint Capital Management LP245,787$1.47M0.0%+77.3%0.979% 5/10/2023 MAI Capital Management53,428$319K0.0%+96.2%0.213% 5/8/2023 Federated Hermes Inc.78,390$469K0.0%-2.0%0.312% 5/5/2023 Carlyle Group Inc.2,073,957$12.24M0.4%N/A8.259% 2/15/2023 Tang Capital Management LLC30,587$71K0.0%N/A0.125% 2/9/2023 MAI Capital Management27,232$63K0.0%-56.9%0.111% Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link.2/1/2023 Bank of Montreal Can33,500$80K0.0%N/A0.137% 11/14/2022Ergoteles LLC37,640$126K0.0%-11.2%0.153% 11/3/2022 Barclays PLC71,930$241K0.0%+33.3%0.294% 9/16/2022 Federated Hermes Inc.30,000$80K0.0%+76.5%0.123% 5/4/2022Commonwealth Equity Services LLC22,347$65K0.0%N/A0.091% 5/4/2022 Tybourne Capital Management HK Ltd.700,000$2.06M0.1%-6.7%2.862% 2/10/2022 Qube Research & Technologies Ltd13,482$115K0.0%N/A0.055% 2/8/2022 Northern Trust Corp63,547$544K0.0%+7.7%0.260% 2/1/2022 Qube Research & Technologies Ltd13,482$115K0.0%N/A0.055% 11/15/2021 Rock Springs Capital Management LP1,143,185$8.52M0.2%+1.3%4.684% 11/15/2021 Franklin Resources Inc.450,000$3.35M0.0%-10.0%1.844% 11/9/2021BlackRock Inc.294,281$2.19M0.0%+1.5%1.206% 11/2/2021 New York State Common Retirement Fund4,210$31K0.0%-67.6%0.017% 8/17/2021 Caas Capital Management LP20,000$187K0.0%N/A0.082% 8/16/2021 California State Teachers Retirement System8,726$81K0.0%N/A0.036% 8/16/2021 RA Capital Management L.P.62,217$580K0.0%N/A0.255% 8/16/2021 Tudor Investment Corp Et Al13,406$125K0.0%N/A0.055% 8/16/2021Pinz Capital Management LP56,823$530K0.2%N/A0.233% 8/16/2021 Charles Schwab Investment Management Inc.13,371$125K0.0%N/A0.055% 8/16/2021 State Street Corp60,915$568K0.0%N/A0.250% 8/16/2021 Federated Hermes Inc.17,000$159K0.0%N/A0.070% 8/13/2021 Northern Trust Corp68,447$639K0.0%N/A0.282% 8/13/2021 Franklin Resources Inc.500,000$4.67M0.0%N/A2.059% 8/13/2021 Geode Capital Management LLC72,069$672K0.0%N/A0.297% 8/13/2021 Vanguard Group Inc.366,210$3.42M0.0%N/A1.508% 8/13/2021 FMR LLC187,500$1.75M0.0%N/A0.772% 8/12/2021 JPMorgan Chase & Co.7,794$73K0.0%N/A0.032% 8/11/2021 RiverVest Venture Management LLC2,409,220$22.48M4.4%N/A9.920% 8/11/2021 Bank of New York Mellon Corp14,837$138K0.0%N/A0.061% 8/11/2021BlackRock Inc.289,824$2.70M0.0%N/A1.193% 8/11/2021 Deutsche Bank AG3,745$35K0.0%N/A0.015% 8/10/2021 Nicholas Investment Partners LP226,189$2.11M0.1%N/A0.931% 8/6/2021 Aisling Capital Management LP886,075$8.27M1.3%N/A3.649% 8/2/2021 New York State Common Retirement Fund12,980$121K0.0%N/A0.053% 8/2/2021 NEA Management Company LLC4,786,921$44.66M0.6%N/A19.711% (Data available from 1/1/2016 forward) RPHM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RPHM shares? During the previous two years, 30 institutional investors and hedge funds held shares of Reneo Pharmaceuticals. The most heavily invested institutionals were Carlyle Group Inc. ($17.68M), Eventide Asset Management LLC ($15.83M), Franklin Resources Inc. ($8.82M), Great Point Partners LLC ($7.11M), BML Capital Management LLC ($5.88M), Highbridge Capital Management LLC ($4.40M), and ExodusPoint Capital Management LP ($3.64M).Learn more on RPHM's institutional investors. What percentage of Reneo Pharmaceuticals stock is owned by institutional investors? 90.98% of Reneo Pharmaceuticals stock is owned by institutional investors. Learn more on RPHM's institutional investor holdings. Which institutional investors have been buying Reneo Pharmaceuticals stock? Of the 26 institutional investors that purchased Reneo Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.96M), Carlyle Group Inc. ($2.70M), Highbridge Capital Management LLC ($1.30M), Great Point Partners LLC ($1.08M), Ikarian Capital LLC ($1.03M), Franklin Resources Inc. ($937.54K), and Vestal Point Capital LP ($654.40K). How much institutional buying is happening at Reneo Pharmaceuticals? Institutional investors have bought a total of 12,393,551 shares in the last 24 months. This purchase volume represents approximately $47.19M in transactions. Which Reneo Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reneo Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($151.10K), MAI Capital Management ($35.98K), Octagon Capital Advisors LP ($29.87K), Fifth Lane Capital LP ($7.37K), and Federated Hermes Inc. ($1.61K). How much institutional selling is happening at Reneo Pharmaceuticals? Institutional investors have sold a total of 225,918 shares in the last 24 months. This volume of shares sold represents approximately $381.63K in transactions. Related Companies BNTC Institutional Ownership ACB Institutional Ownership FATE Institutional Ownership NGNE Institutional Ownership BMEA Institutional Ownership SLN Institutional Ownership ZNTL Institutional Ownership STRO Institutional Ownership TCRX Institutional Ownership TRVI Institutional Ownership This page (NASDAQ:RPHM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reneo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPHM Stock Alerts